About Viome Life Sciences
Viome Life Sciences is a company based in Bothell (United States) founded in 2016 by Momchilo Momo Vuyisich and Naveen Jain.. Viome Life Sciences has raised $92.44 million across 2 funding rounds from investors including Khosla Ventures, Glico Group and BOLD Capital Group. Viome Life Sciences offers products and services including Diagnostic Tests, Precision Nutrition, Predictive Biomarkers, and Therapeutics Development. Viome Life Sciences operates in a competitive market with competitors including Prometheus Laboratories, InDex Pharmaceuticals, NinePoint Medical, Proteomics International and Given Imaging, among others.
- Headquarter Bothell, United States
- Founders Momchilo Momo Vuyisich, Naveen Jain
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Viome Life Sciences, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$92.44 M (USD)
in 2 rounds
-
Latest Funding Round
$25.44 M (USD), Series C
Aug 19, 2024
-
Investors
Khosla Ventures
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Viome Life Sciences
Viome Life Sciences offers a comprehensive portfolio of products and services, including Diagnostic Tests, Precision Nutrition, Predictive Biomarkers, and Therapeutics Development. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Analyzes RNA for predictive health insights and chronic disease detection.
Provides tailored nutrition plans based on microbiome data for wellness.
Identifies disease signatures through microbial analysis for early intervention.
Develops drugs and vaccines targeting microbiome-related conditions.
Unlock access to complete
Unlock access to complete
Funding Insights of Viome Life Sciences
Viome Life Sciences has successfully raised a total of $92.44M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $25.44 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series C — $25.4M
-
First Round
First Round
(18 Oct 2022)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2024 | Amount | Series C - Viome Life Sciences | Valuation |
investors |
|
| Oct, 2022 | Amount | Series C - Viome Life Sciences | Valuation | BOLD Capital Group |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Viome Life Sciences
Viome Life Sciences has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Khosla Ventures, Glico Group and BOLD Capital Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are funded by this venture capital firm.
|
Founded Year | Domain | Location | |
|
Investments are focused across multiple sectors by the firm.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in companies across multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Viome Life Sciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Viome Life Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Viome Life Sciences Comparisons
Competitors of Viome Life Sciences
Viome Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prometheus Laboratories, InDex Pharmaceuticals, NinePoint Medical, Proteomics International and Given Imaging, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Diagnostics and therapeutics for gastrointestinal and personalized medicine are developed.
|
|
| domain | founded_year | HQ Location |
DNA-based immunomodulatory drugs for ulcerative colitis are developed.
|
|
| domain | founded_year | HQ Location |
Optical coherence tomography systems for tissue microstructure imaging are developed.
|
|
| domain | founded_year | HQ Location |
Medical technology company at the forefront of predictive diagnostics and bio-analytical services
|
|
| domain | founded_year | HQ Location |
Capsule endoscopy systems for GI imaging
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Viome Life Sciences
Frequently Asked Questions about Viome Life Sciences
When was Viome Life Sciences founded?
Viome Life Sciences was founded in 2016 and raised its 1st funding round 6 years after it was founded.
Where is Viome Life Sciences located?
Viome Life Sciences is headquartered in Bothell, United States. It is registered at Bothell, Washington, United States.
Who is the current CEO of Viome Life Sciences?
Naveen Jain is the current CEO of Viome Life Sciences. They have also founded this company.
Is Viome Life Sciences a funded company?
Viome Life Sciences is a funded company, having raised a total of $92.44M across 2 funding rounds to date. The company's 1st funding round was a Series C of $67M, raised on Oct 18, 2022.
What does Viome Life Sciences do?
Provider of tests to prevent, treat, and cure chronic diseases, and cancer. It uses AI and proprietary mRNA sequencing technology to develop a CancerDetect test for oral throat cancer. The company platform enables to development of predictive biomarkers, precision diagnostics, and precision therapeutics to prevent and intercept chronic diseases. It has also developed 30 predictive models for Glycemic response, Obesity, Diabetes, Depression, IBS, and Oral Cancer.
Who are the top competitors of Viome Life Sciences?
Viome Life Sciences's top competitors include Prometheus Laboratories, NinePoint Medical and Proteomics International.
What products or services does Viome Life Sciences offer?
Viome Life Sciences offers Diagnostic Tests, Precision Nutrition, Predictive Biomarkers, and Therapeutics Development.
Who are Viome Life Sciences's investors?
Viome Life Sciences has 6 investors. Key investors include Khosla Ventures, Glico Group, BOLD Capital Group, WestRiver Group, and Ocgrow Group of Companies.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.